{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:40:12Z","timestamp":1783510812054,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2015\/009127"],"award-info":[{"award-number":["EMR\/2015\/009127"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36379-4","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T14:03:10Z","timestamp":1769263390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["MGMT upregulation mediates Temozolomide resistance conferred USP5 dependency"],"prefix":"10.1038","volume":"16","author":[{"given":"Sachin","family":"Bhardwaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Sanjay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devansh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshay","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birender K.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"36379_CR1","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/neuonc\/noab003","volume":"23","author":"S Wu","year":"2021","unstructured":"Wu, S. et al. PARP-mediated parylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma. Neuro-Oncology 23, 920\u2013931. https:\/\/doi.org\/10.1093\/neuonc\/noab003 (2021).","journal-title":"Neuro-Oncology"},{"key":"36379_CR2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1215\/15228517-2009-001","volume":"11","author":"S Everhard","year":"2009","unstructured":"Everhard, S. et al. Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas. Neuro-Oncology 11, 348\u2013356. https:\/\/doi.org\/10.1215\/15228517-2009-001 (2009).","journal-title":"Neuro-Oncology"},{"key":"36379_CR3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00401-011-0803-5","volume":"121","author":"DS Malley","year":"2011","unstructured":"Malley, D. S. et al. A distinct region of the MGMT CpG Island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts. Acta Neuropathol. 121, 651\u2013661. https:\/\/doi.org\/10.1007\/s00401-011-0803-5 (2011).","journal-title":"Acta Neuropathol."},{"key":"36379_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/neuonc\/nop050","volume":"12","author":"AA Brandes","year":"2010","unstructured":"Brandes, A. A. et al. O6-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications. Neuro-Oncology 12, 283\u2013288. https:\/\/doi.org\/10.1093\/neuonc\/nop050 (2010).","journal-title":"Neuro-Oncology"},{"key":"36379_CR5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/ijc.26083","volume":"129","author":"J Felsberg","year":"2011","unstructured":"Felsberg, J. et al. Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas. Intl J. Cancer. 129, 659\u2013670. https:\/\/doi.org\/10.1002\/ijc.26083 (2011).","journal-title":"Intl J. Cancer"},{"key":"36379_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/jnc.14262","volume":"144","author":"D Aasland","year":"2018","unstructured":"Aasland, D. et al. Repair gene O6 -methylguanine\u2010DNA methyltransferase is controlled by SP1 and up\u2010regulated by glucocorticoids, but not by Temozolomide and radiation. J. Neurochem. 144, 139\u2013151. https:\/\/doi.org\/10.1111\/jnc.14262 (2018).","journal-title":"J. Neurochem."},{"key":"36379_CR7","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1093\/brain\/aww046","volume":"139","author":"KL Pitter","year":"2016","unstructured":"Pitter, K. L. et al. Corticosteroids compromise survival in glioblastoma. Brain 139, 1458\u20131471. https:\/\/doi.org\/10.1093\/brain\/aww046 (2016).","journal-title":"Brain"},{"key":"36379_CR8","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/jnc.14280","volume":"144","author":"A Chumakova","year":"2018","unstructured":"Chumakova, A. & Lathia, J. D. Outlining involvement of stem cell program in regulation of O6-methylguanine DNA methyltransferase and development of Temozolomide resistance in glioblastoma: an editorial highlight for \u2018Transcriptional control of O6 \u2010methylguanine DNA methyltransferase expression and Temozolomide resistance in glioblastoma\u2019 on page 780. J. Neurochem. 144, 688\u2013690. https:\/\/doi.org\/10.1111\/jnc.14280 (2018).","journal-title":"J. Neurochem."},{"key":"36379_CR9","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/jnc.14326","volume":"144","author":"C Happold","year":"2018","unstructured":"Happold, C. et al. Transcriptional control of O6 -methylguanine DNA methyltransferase expression and Temozolomide resistance in glioblastoma. J. Neurochem. 144, 780\u2013790. https:\/\/doi.org\/10.1111\/jnc.14326 (2018).","journal-title":"J. Neurochem."},{"key":"36379_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.bcp.2018.10.029","volume":"158","author":"S-H Hsu","year":"2018","unstructured":"Hsu, S-H., Chen, S-H., Kuo, C-C. & Chang, J-Y. Ubiquitin-conjugating enzyme E2 B regulates the ubiquitination of O-methylguanine-DNA methyltransferase and BCNU sensitivity in human nasopharyngeal carcinoma cells. Biochem. Pharmacol. 158, 327\u2013338. https:\/\/doi.org\/10.1016\/j.bcp.2018.10.029 (2018).","journal-title":"Biochem. Pharmacol."},{"key":"36379_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3233\/CBM-210345","volume":"34","author":"X Li","year":"2022","unstructured":"Li, X. et al. Ubiquitination and degradation of MGMT by TRIM72 increases the sensitivity of uveal melanoma cells to Dacarbazine treatment. CBM 34, 275\u2013284. https:\/\/doi.org\/10.3233\/CBM-210345 (2022).","journal-title":"CBM"},{"key":"36379_CR12","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1158\/0008-5472.CAN-09-3979","volume":"70","author":"A Panner","year":"2010","unstructured":"Panner, A. et al. Ubiquitin-Specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme. Cancer Res. 70, 5046\u20135053. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3979 (2010).","journal-title":"Cancer Res."},{"key":"36379_CR13","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1038\/ncomms4214","volume":"5","author":"H-C Wu","year":"2014","unstructured":"Wu, H-C. et al. USP11 regulates PML stability to control Notch-induced malignancy in brain tumours. Nat. Commun. 5, 3214. https:\/\/doi.org\/10.1038\/ncomms4214 (2014).","journal-title":"Nat. Commun."},{"key":"36379_CR14","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1038\/ncomms5632","volume":"5","author":"D Annibali","year":"2014","unstructured":"Annibali, D. et al. Myc Inhibition is effective against glioma and reveals a role for Myc in proficient mitosis. Nat. Commun. 5, 4632. https:\/\/doi.org\/10.1038\/ncomms5632 (2014).","journal-title":"Nat. Commun."},{"key":"36379_CR15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1101\/sqb.2008.73.047","volume":"73","author":"H Zheng","year":"2008","unstructured":"Zheng, H. et al. Pten and p53 converge on c-Myc to control Differentiation, Self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma. Cold Spring Harb. Symp. Quant. Biol. 73, 427\u2013437. https:\/\/doi.org\/10.1101\/sqb.2008.73.047 (2008).","journal-title":"Cold Spring Harb. Symp. Quant. Biol"},{"key":"36379_CR16","doi-asserted-by":"publisher","first-page":"10983","DOI":"10.1073\/pnas.1802932115","volume":"115","author":"X-X Sun","year":"2018","unstructured":"Sun, X-X. et al. SUMO protease SENP1 desumoylates and stabilizes c-Myc. Proc. Natl. Acad. Sci. USA. 115, 10983\u201310988. https:\/\/doi.org\/10.1073\/pnas.1802932115 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"36379_CR17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/1873-3468.14296","volume":"596","author":"M Nagasaka","year":"2022","unstructured":"Nagasaka, M. et al. The deubiquitinating enzyme USP17 regulates c-Myc levels and controls cell proliferation and Glycolysis. FEBS Lett. 596, 465\u2013478. https:\/\/doi.org\/10.1002\/1873-3468.14296 (2022).","journal-title":"FEBS Lett."},{"key":"36379_CR18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ncb1601","volume":"9","author":"N Popov","year":"2007","unstructured":"Popov, N. et al. The ubiquitin-specific protease USP28 is required for MYC stability. Nat. Cell. Biol. 9, 765\u2013774. https:\/\/doi.org\/10.1038\/ncb1601 (2007).","journal-title":"Nat. Cell. Biol."},{"key":"36379_CR19","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1073\/pnas.1411713112","volume":"112","author":"X-X Sun","year":"2015","unstructured":"Sun, X-X. et al. The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc. Proc. Natl. Acad. Sci. USA. 112, 3734\u20133739. https:\/\/doi.org\/10.1073\/pnas.1411713112 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"36379_CR20","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1038\/onc.2014.327","volume":"34","author":"J Pan","year":"2015","unstructured":"Pan, J. et al. USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer. Oncogene 34, 3957\u20133967. https:\/\/doi.org\/10.1038\/onc.2014.327 (2015).","journal-title":"Oncogene"},{"key":"36379_CR21","doi-asserted-by":"publisher","first-page":"720307","DOI":"10.3389\/fphar.2021.720307","volume":"12","author":"G Li","year":"2021","unstructured":"Li, G. et al. USP5 sustains the proliferation of glioblastoma through stabilization of CyclinD1. Front. Pharmacol. 12, 720307. https:\/\/doi.org\/10.3389\/fphar.2021.720307 (2021).","journal-title":"Front. Pharmacol."},{"key":"36379_CR22","doi-asserted-by":"publisher","first-page":"8972","DOI":"10.1038\/s41598-023-35793-2","volume":"13","author":"B Yan","year":"2023","unstructured":"Yan, B. et al. A pan-cancer analysis of the role of USP5 in human cancers. Sci. Rep. 13, 8972. https:\/\/doi.org\/10.1038\/s41598-023-35793-2 (2023).","journal-title":"Sci. Rep."},{"key":"36379_CR23","doi-asserted-by":"publisher","first-page":"216875","DOI":"10.1016\/j.canlet.2024.216875","volume":"593","author":"X Jiang","year":"2024","unstructured":"Jiang, X. et al. E2F1-regulated USP5 contributes to the tumorigenic capacity of glioma stem cells through the maintenance of OCT4 stability. Cancer Lett. 593, 216875. https:\/\/doi.org\/10.1016\/j.canlet.2024.216875 (2024).","journal-title":"Cancer Lett."},{"key":"36379_CR24","doi-asserted-by":"publisher","first-page":"100846","DOI":"10.1016\/j.bbrep.2020.100846","volume":"24","author":"V Vashistha","year":"2020","unstructured":"Vashistha, V., Bhardwaj, S., Yadav, B. K. & Yadav, A. K. Depleting deubiquitinating enzymes promotes apoptosis in glioma cell line via RNA binding proteins SF2\/ASF1. Biochem. Biophys. Rep. 24, 100846. https:\/\/doi.org\/10.1016\/j.bbrep.2020.100846 (2020).","journal-title":"Biochem. Biophys. Rep."},{"key":"36379_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11060-024-04831-y","volume":"171","author":"S Bhardwaj","year":"2025","unstructured":"Bhardwaj, S. & Sanjay, Yadav, A. K. Higher isoform of hnRNPA1 confer Temozolomide resistance in U87MG & LN229 glioma cells. J. Neurooncol. 171, 47\u201363. https:\/\/doi.org\/10.1007\/s11060-024-04831-y (2025).","journal-title":"J. Neurooncol"},{"key":"36379_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1471-2407-13-147","volume":"13","author":"EC Filippi-Chiela","year":"2013","unstructured":"Filippi-Chiela, E. C. et al. Resveratrol abrogates the Temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the Temozolomide-induced senescence in glioma cells. BMC Cancer. 13, 147. https:\/\/doi.org\/10.1186\/1471-2407-13-147 (2013).","journal-title":"BMC Cancer"},{"key":"36379_CR27","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.1038\/s41598-018-25169-2","volume":"8","author":"AA Pandith","year":"2018","unstructured":"Pandith, A. A. et al. Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide). Sci. Rep. 8, 6704. https:\/\/doi.org\/10.1038\/s41598-018-25169-2 (2018).","journal-title":"Sci. Rep."},{"key":"36379_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5732\/cjc.012.10236","volume":"33","author":"Z-K Qiu","year":"2014","unstructured":"Qiu, Z-K. et al. Enhanced MGMT expression contributes to Temozolomide resistance in glioma stem-like cells. Chin. J. Cancer. 33, 115\u2013122. https:\/\/doi.org\/10.5732\/cjc.012.10236 (2014).","journal-title":"Chin. J. Cancer"},{"key":"36379_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41419-023-05734-y","volume":"14","author":"W Qiu","year":"2023","unstructured":"Qiu, W. et al. USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma. Cell. Death Dis. 14, 207. https:\/\/doi.org\/10.1038\/s41419-023-05734-y (2023).","journal-title":"Cell. Death Dis."},{"key":"36379_CR30","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s13046-021-02163-7","volume":"40","author":"R Chauhan","year":"2021","unstructured":"Chauhan, R. et al. Ubiquitin-specific peptidase 37: an important cog in the oncogenic machinery of cancerous cells. J. Exp. Clin. Cancer Res. 40, 356. https:\/\/doi.org\/10.1186\/s13046-021-02163-7 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"36379_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.bbrc.2018.05.156","volume":"502","author":"AT Ouchida","year":"2018","unstructured":"Ouchida, A. T. et al. USP10 regulates the stability of the EMT-transcription factor Slug\/SNAI2. Biochem. Biophys. Res. Commun. 502, 429\u2013434. https:\/\/doi.org\/10.1016\/j.bbrc.2018.05.156 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"36379_CR32","doi-asserted-by":"publisher","first-page":"e011653","DOI":"10.1136\/jitc-2025-011653","volume":"13","author":"JY Zhang","year":"2025","unstructured":"Zhang, J. Y. et al. High MGMT expression identifies aggressive colorectal cancer with distinct genomic features and immune evasion properties. J. Immunother Cancer. 13, e011653. https:\/\/doi.org\/10.1136\/jitc-2025-011653 (2025).","journal-title":"J. Immunother Cancer"},{"key":"36379_CR33","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/s41419-021-04356-6","volume":"12","author":"J Pan","year":"2021","unstructured":"Pan, J. et al. USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1. Cell. Death Dis. 12, 1051. https:\/\/doi.org\/10.1038\/s41419-021-04356-6 (2021).","journal-title":"Cell. Death Dis."},{"key":"36379_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov, H., Orhan, A., Christensen, J. P. & G\u00f6genur, I. Cytotoxic CD8\u2009+\u2009T cells in cancer and cancer immunotherapy. Br. J. Cancer. 124, 359\u2013367. https:\/\/doi.org\/10.1038\/s41416-020-01048-4 (2021).","journal-title":"Br. J. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36379-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36379-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36379-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T23:03:08Z","timestamp":1770937388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36379-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36379"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36379-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Protocols for the handling of human tissues and cells were approved by the Ethics committee of Dr. B.R Ambedkar Center for Biomedical Research (No.F.50\u2009\u2212\u20092\/Eth.Com\/ACBR\/16\/2379) and Rajiv Gandhi Cancer Institute and Research Centre (Res\/SCM\/17\/2016\/59).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participation"}}],"article-number":"6118"}}